BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and structure-activity relationship of novel CCR2 antagonists. 2009

Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.

A series of novel 1-aminocyclopentyl-3-carboxyamides incorporating substituted tetrahydropyran moieties have been synthesized and subsequently evaluated for their antagonistic activity against the human CCR2 receptor. Among them analog 59 was found to posses potent antagonistic activity.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
December 2008, Bioorganic & medicinal chemistry letters,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists.
April 2018, European journal of medicinal chemistry,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.
November 2007, Journal of medicinal chemistry,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Discovery of novel PTHR1 antagonists: Design, synthesis, and structure activity relationships.
September 2019, Bioorganic & medicinal chemistry letters,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
August 2009, Journal of medicinal chemistry,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design, synthesis and structure-activity relationship of novel diphenylamine derivatives.
February 2016, Bioorganic & medicinal chemistry,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design, synthesis and structure-activity relationship of novel coumarin derivatives.
June 2011, Pest management science,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.
November 2022, Bioorganic & medicinal chemistry letters,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.
November 1999, Journal of medicinal chemistry,
Shankaran Kothandaraman, and Karla L Donnely, and Gabor Butora, and Richard Jiao, and Alexander Pasternak, and Gregori J Morriello, and Stephen D Goble, and Changyou Zhou, and Sander G Mills, and Malcolm Maccoss, and Pasquale P Vicario, and Julia M Ayala, and Julie A Demartino, and Mary Struthers, and Margaret A Cascieri, and Lihu Yang
Design, synthesis, and structure--activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists.
January 2015, European journal of medicinal chemistry,
Copied contents to your clipboard!